Table of Content
1 Industrial Chain Overview
1.1 Custom Antibody Services Industry
1.1.1 Overview
Figure Custom Antibody Services Picture List
1.1.2 Characteristics of Custom Antibody Services
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Monoclonal
1.3.2 Polyclonal
1.3.3 Others
1.4 End-Use List
1.4.1 Demand in BioScience Companies
1.4.2 Demand in BioScience Research Institutions
1.4.3 Demand in Hospitals
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Production Amount List in 2021
3.2 Manufacturers List
3.2.1 ThermoFisher Overview
Table ThermoFisher Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of ThermoFisher (Production Amount (Million USD), Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 GenScript Overview
Table GenScript Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of GenScript (Production Amount (Million USD), Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Abcam Overview
Table Abcam Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of Abcam (Production Amount (Million USD), Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 MBS Overview
Table MBS Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of MBS (Production Amount (Million USD), Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 ROCKLAND Overview
Table ROCKLAND Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of ROCKLAND (Production Amount (Million USD), Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 ProSci Overview
Table ProSci Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of ProSci (Production Amount (Million USD), Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Biocompare Overview
Table Biocompare Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of Biocompare (Production Amount (Million USD), Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Bio-Rad Overview
Table Bio-Rad Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of Bio-Rad (Production Amount (Million USD), Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Covance Overview
Table Covance Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of Covance (Production Amount (Million USD), Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Capra Science Overview
Table Capra Science Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of Capra Science (Production Amount (Million USD), Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Innovagen Overview
Table Innovagen Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of Innovagen (Production Amount (Million USD), Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 LIFE SCIENCE GROUP Overview
Table LIFE SCIENCE GROUP Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of LIFE SCIENCE GROUP (Production Amount (Million USD), Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Randox Overview
Table Randox Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of Randox (Production Amount (Million USD), Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 GL Biochem Overview
Table GL Biochem Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of GL Biochem (Production Amount (Million USD), Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Abgent Overview
Table Abgent Overview List
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Amount (Million USD), Cost, Margin)
Table Custom Antibody Services Business Operation of Abgent (Production Amount (Million USD), Cost, Gross Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
5.2 Segment Subdivision by Product Type
5.2.1 Market in Monoclonal
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Monoclonal, 2017-2021, in USD Million
5.2.1.2 Situation & Development
5.2.2 Market in Polyclonal
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Polyclonal, 2017-2021, in USD Million
5.2.2.2 Situation & Development
5.2.3 Market in Others
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
5.2.3.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
6.2 Segment Subdivision
6.2.1 Market in BioScience Companies
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in BioScience Companies, 2017-2021, in USD Million
6.2.1.2 Situation & Development
6.2.2 Market in BioScience Research Institutions
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in BioScience Research Institutions, 2017-2021, in USD Million
6.2.2.2 Situation & Development
6.2.3 Market in Hospitals
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Hospitals, 2017-2021, in USD Million
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Custom Antibody Services Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion